| First author (year) | Donor pig | Recipient NHP | Immunosuppressive regimen | Longest survival (days) |
| Heart xenotransplantation, heterotopic | Buhler (2000) [86] | WT | Baboon | TBI, TI, splenectomy, IA, ATG, CVF, CSA, or anti-CD154mAb, MMF +/− pig stem cells | N.A | Houser (2004) [87] | CD55 | Baboon | ATG, anti-CD2mAb, TI, CVF, anti-CD154mAb, MMF, CS | 139 | Dor (2005) [88] | GTKO | Baboon | ATG, anti-CD154mAb, MMF, CS | 179 | Kuwaki (2005) [89] | GTKO | Baboon | ATG, anti-CD2mAb, TI, CVF, anti-CD154mAb | 179 | Wu (2005) [90] | CD46 | Baboon | ATG, anti-CD154mAb, +/− anti-CD20mAb +/− CTLA4-Fc | 11 | Wu (2007) [91] | CD46 | Baboon | ATG, anti-CD154mAb, GAS194 or TPC, +/− IA | 36 | Ezzelarab (2009) [92] | GTKO | Baboon | ATG, CVF, anti-CD154mAb, MMF, CS | 56 | Mohiuddin (2012) [93] | GTKO.CD46 | Baboon | ATG, anti-CD20mAb, anti-CD154mAb, MMF, CS | 236 | Kim (2013) [94] | GTKO | Cynomolgus | ATG, anti-CD20mAb, anti-CD154mAb, tacrolimus, CS | 24 | Ezzelarab (2015) [95] | GTKO | Baboon | ATG, anti-CD154mAb, MMF | 56 | Iwase (2015) [96] | GTKO.CD46.TBM | Baboon | ATG, anti-CD20mAb, anti-CD154mAb, MMF, CS | 52 | Kidney xenotransplantation | Buhler (2000) [86] | WT | Baboon | TBI, TI, splenectomy, IA, ATG, CVF, CSA, or anti-CD154mAb, MMF +/− pig stem cells | N.A | Buhler (2001) [97] | CD55 | Baboon | TBI, TI, splenectomy, IA, ATG, CVF, anti-CD154mAb, MMF, CS | 29 | Barth (2003) [98] | CD55 | Baboon | Thymokidneys, anti-CD2mAb, ATG, anti-CD154mAb, CyP, CVF, MMF, CS | 229 | Gollackner (2003) [99] | CD55 | Baboon | TI, splenectomy, IA, ATG, anti-CD154mAb, CyP, CVF, MMF, CS | 13 | Knosalla (2003) [100] | CD55 | Baboon | TI, splenectomy, IA, ATG, anti-CD154mAb, CyP, CVF, MMF, CS | 29 | Yamada (2005) [75] | GTKO | Baboon | Vascularized thymic lobe, WBI, anti-CD2mAb, anti-CD154mAb, MMF, CS, CVF | 68 | Shimizu (2005) [101] | CD55 | Baboon | Thymokidneys, splenectomy, IA, anti-CD3mAb, ATG, anti-CD154mAb, CyP, CVF, MMF | 30 | Griesemer (2009) [102] | GTKO | Baboon | Thymectomy, splenectomy, TBI, ATG, anti-CD2mAb, anti-CD154mAb, tacrolimus, MMF, anti-CD20mAb | 83 | Lin (2010) [103] | GTKO.CD46 | Baboon | ATG, antiCD154mAb, MMF, CVF, CS | 16 | Nishimura (2011) [104] | GTKO | Baboon | Thymokidney, thymectomy, splenectomy, anti-CD3, antiCD2mAb, ATG, anti-CD20mAb, tacrolimus, MMF, anti-CD154mAb | 15 | Ezzelarab (2015) [95] | GTKO | Baboon | ATG, anti-CD154mAb, MMF | 10 | Higginbotham (2015) [22] | GTKO.CD55 | Rhesus | Anti-CD4, anti-CD8, anti-CD154mAb, MMF, CS | 310 | Kim (2017) [76] | GTKO.CD55 | Rhesus | Anti-CD4, anti-CD8, anti-CD154mAb, MMF, CS | 405 | Liver xenotransplantation | Kim (2002) [105] | GTKO | Baboon | ATG, LoCD2b, CVF, anti-CD154mAb, azathioprine, tacrolimus, CS | 9 | Navarro-Alvarez (2016) [106] | GTKO | Baboon | ATG, LoCD2b, CVF, anti-CD154mAb, tacrolimus, CS | 6 | Islet xenotransplantation | Buhler (2002) [18] | WT | Baboon | Splenectomy, IA, TBI, ATG, CVF, anti-CD154mAb, CSA, MMF, CS | 28 | Hering (2006) [107] | WT | Cynomolgus | Anti-CD25mAb, FTY720, rapamycin, anti-CD154mAb | 187 | Cardona (2006) [108] | WT | Rhesus | Anti-CD25mAb, anti-CD154mAb, CTLA4-Ig | >260 | Rood (2007) [109] | GTKO | Cynomolgus | ATG, CVF, anti-CD154mAb, MMF, tacrolimus | >58 | Casu (2008) [110] | WT | Cynomolgus | ATG, anti-CD154mAb, MMF | >60 | van der Windt (2009) [19] | CD46 | Cynomolgus | ATG, anti-CD154mAb, MMF | 396 | Thompson (2011) [20] | GTKO | Rhesus | Anti-CD154mAb, anti-LFA1mAb, MMF, belatacept | 249 | Bottino (2014) [111] | GTKO.CD46. TFPI.CTLA4Ig.CD39 | Cynomolgus | ATG, MMF, anti-CD154mAb, CS | 365 | Shin (2015) [112] | WT | Rhesus | Anti-CD154mAb, ATG, rapamycin, CVF, adalimumab | >603 |
|
|